KVK Reaches Global Resolution of DOJ Litigation
To resolve these charges, KVK has agreed to enter into a Deferred Prosecution Agreement (DPA) with the government that will, among other things, require that company to operate with an independent compliance monitor for the next three years. Also, KVK Research has agreed to plead guilty to the two misdemeanor counts charged and to pay financial penalties.
After Research is sentenced and the DPA is entered, the DOJ has agreed to dismiss all charges against the two individual defendants Murty Vepuri and
"KVK looks forward to putting this litigation behind us. We will continue to focus on providing high-quality, affordable generic pharmaceuticals to the American public" said Anthony Tabasso, KVK's CEO. "KVK remains committed to maintaining the highest levels of integrity, and we look forward to continuing to work with all relevant stakeholders to uphold those standards."
About KVK
Founded in 2004, KVK has fast become a trusted leader in specialty pharmaceutical manufacturing. KVK is a leader in the development and manufacture of high-quality, FDA-approved medicines that address unmet patient needs. KVK takes pride in its ability to advance medical care and offer low-cost alternatives in response to today's healthcare challenges. The dedicated team is comprised of individuals with the technical, clinical and business expertise that is necessary for innovation that results in the development of a diverse range of life-changing medicines for patients of all socio-economic levels. Learn more at https://kvktech.com/
View original content to download multimedia:https://www.prnewswire.com/news-releases/kvk-reaches-global-resolution-of-doj-litigation-302071580.html
SOURCE KVK Tech, Inc.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- BAE Systems OneArc integrates commercial embedded training on Army combat vehicles during Force Development Innovation & Assessment (FDIA)
- Tanmiah Inaugurates its state-of-the-art Innovation Center, bringing the full innovation journey under one roof
- DIALOG CAFÉ TO OPEN RESIDENCY AT THE SUN ROSE WEST HOLLYWOOD
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesRelated Entities
FDASign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share